S100A4
Basic information
Region (hg38): 1:153543613-153550136
Previous symbols: [ "MTS1", "CAPL" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the S100A4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 2 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 2 | 0 | 4 |
Variants in S100A4
This is a list of pathogenic ClinVar variants found in the S100A4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-153543831-G-A | Benign (Dec 31, 2019) | |||
1-153543860-C-T | not specified | Uncertain significance (Oct 12, 2021) | ||
1-153543861-G-A | Benign (Mar 02, 2018) | |||
1-153543882-G-A | Benign (Dec 31, 2019) | |||
1-153544656-C-T | not specified | Uncertain significance (Jan 03, 2022) | ||
1-153544735-C-T | Benign (Dec 31, 2019) | |||
1-153547699-G-A | not specified | Uncertain significance (Sep 29, 2023) | ||
1-153547710-C-A | not specified | Uncertain significance (Dec 19, 2023) | ||
1-153547718-G-C | not specified | Uncertain significance (Jun 29, 2022) | ||
1-153547759-G-A | Benign (Apr 04, 2024) | |||
1-153547804-G-C | Likely benign (Mar 01, 2024) | |||
1-153547821-T-C | not specified | Uncertain significance (Mar 01, 2024) | ||
1-153547833-T-C | not specified | Uncertain significance (Mar 08, 2024) | ||
1-153547845-G-C | not specified | Uncertain significance (Jan 10, 2022) | ||
1-153548404-T-C | not specified | Uncertain significance (May 30, 2024) | ||
1-153548428-C-T | not specified | Uncertain significance (Nov 09, 2023) | ||
1-153548449-C-A | not specified | Uncertain significance (Jun 29, 2022) | ||
1-153548461-C-A | Malignant tumor of prostate | Uncertain significance (-) | ||
1-153548463-G-A | not specified | Uncertain significance (Jan 04, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
S100A4 | protein_coding | protein_coding | ENST00000368716 | 2 | 6524 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00618 | 0.519 | 125706 | 0 | 41 | 125747 | 0.000163 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.365 | 48 | 55.7 | 0.862 | 0.00000288 | 682 |
Missense in Polyphen | 13 | 15.532 | 0.837 | 215 | ||
Synonymous | 0.699 | 19 | 23.3 | 0.816 | 0.00000137 | 171 |
Loss of Function | -0.0357 | 3 | 2.93 | 1.02 | 1.22e-7 | 43 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000152 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000255 | 0.000255 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.00 | 0.00 |
Other | 0.000652 | 0.000652 |
dbNSFP
Source:
- Pathway
- Vitamin D Receptor Pathway
(Consensus)
Recessive Scores
- pRec
- 0.520
Intolerance Scores
- loftool
- 0.817
- rvis_EVS
- -0.19
- rvis_percentile_EVS
- 39.68
Haploinsufficiency Scores
- pHI
- 0.262
- hipred
- Y
- hipred_score
- 0.778
- ghis
- 0.610
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.815
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- S100a4
- Phenotype
- immune system phenotype; cellular phenotype; neoplasm; hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype;
Gene ontology
- Biological process
- epithelial to mesenchymal transition;positive regulation of I-kappaB kinase/NF-kappaB signaling
- Cellular component
- extracellular region;extracellular space;nucleus;neuron projection;perinuclear region of cytoplasm;extracellular exosome
- Molecular function
- RNA binding;actin binding;calcium ion binding;protein binding;identical protein binding;transition metal ion binding;calcium-dependent protein binding;RAGE receptor binding